Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 100/100

Failure Rate

40.0%

2 terminated/withdrawn out of 5 trials

Success Rate

50.0%

-36.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
2(40.0%)
Phase 1
2(40.0%)
Phase 2
1(20.0%)
5Total
N/A(2)
Phase 1(2)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT02453373Not ApplicableTerminated

Helping Stroke Patients With ThermoSuit Cooling

Role: lead

NCT00763828Not ApplicableUnknown

Can Hypothermia be Incorporated Into Primary Angioplasty for Heart Attack?

Role: lead

NCT00593164Phase 2Withdrawn

Clinical Study of the LRS ThermoSuit™ System in Post Arrest Patients With Intravenous Infusion of Magnesium Sulfate

Role: lead

NCT00410969Phase 1Completed

Pilot Clinical Study of the LRS ThermoSuit™ System in Post Arrest Patients

Role: lead

NCT00384319Phase 1Completed

Pilot Clinical Study of the LRS ThermoSuit™ System in Post Arrest Patients

Role: lead

All 5 trials loaded